Other
Neoplasm by Morphology
CI-CAN-00000002Explore in graph →
Non-malignant13,319 active trials222 approved drugs2,774 evidence items
- NCIt
- C4741
Loading cancer entity…
Loading cancer entity…
Other
CI-CAN-00000002Explore in graph →
Clinical trials
52,657 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00997724 | Assisted-VATS Sleeve Lobectomy for Non-small Cell Lung Cancer(VATS) | unknown | Phase 2 | 100 | The First Affiliated Hospital of Guangzhou Medical UniversityOTHER | 1 | Jan 5, 2010 | clinicaltrials |
| NCT01039363 | Vorinostat Combined With Gemtuzumab Ozogamicin, Idarubicin and Cytarabine in Acute Myeloid Leukemia | unknown | Phase 2 | 27 | Samsung Medical CenterOTHER | 1 | Dec 25, 2009 |
| clinicaltrials |
| NCT01039181 | Calcitriol in Advanced Intrahepatic Cholangiocarcinoma | unknown | Phase 2 | 28 | National Science and Technology Development Agency, ThailandOTHER_GOV | 1 | Dec 24, 2009 | clinicaltrials |
| NCT00813449 | Safety Study of Combined Chemotherapy and Endostar to Untreated Patients With Advanced Melanoma(melanoma) | unknown | Phase 2 | 140 | Simcere Pharmaceutical Co., LtdOTHER | 1 | Dec 8, 2009 | clinicaltrials |
| NCT01019798 | Salvage Therapy With Sunitinib,Docetaxel and Platinum on Metastatic or Unresectable Non Small Cell Lung Cancer | unknown | Phase 2 | 16 | Taipei Medical University HospitalOTHER | 1 | Nov 25, 2009 | clinicaltrials |
| NCT00999843 | Safety Study of Sorafenib Following Combined Therapy of Radiation and TACE for Liver Cancer | unknown | Phase 1 / Phase 2 | 30 | Fudan UniversityOTHER | 1 | Oct 22, 2009 | clinicaltrials |
| NCT00989352 | Methotrexate-based Chemo-immunotherapy Followed by Maintenance Therapy for Patients > 65 Years With Central Nervous System (CNS)-Lymphoma(PRIMAIN) | unknown | Phase 2 | 56 | University Hospital FreiburgOTHER | 1 | Oct 5, 2009 | clinicaltrials |
| NCT00041730 | Rituxan Plus FavId (Idiotype Vaccine) for Low-grade Non-Hodgkin's Lymphoma | unknown | Phase 2 | 90 | FavrilleINDUSTRY | 1 | Sep 30, 2009 | clinicaltrials |
| NCT00740441 | A Phase II Study of AS1411 in Renal Cell Carcinoma | unknown | Phase 2 | 30 | Antisoma ResearchINDUSTRY | 1 | Sep 25, 2009 | clinicaltrials |
| NCT00980304 | R Retreatment in 1st Relapsed DLBCL | unknown | Phase 2 | — | Shanghai Jiao Tong University School of MedicineOTHER | 0 | Sep 21, 2009 | clinicaltrials |
| NCT00979160 | Evaluation of Response of Dasatinib to Treat Mastocytosis | unknown | Phase 2 | 30 | Federico II UniversityOTHER | 1 | Sep 18, 2009 | clinicaltrials |
| NCT00568841 | Erlotinib and Sequential Positron Emission Tomography (PET) in Advanced Non Small Cell Lung Cancer (NSCLC)(ERLOPET) | unknown | Phase 2 | 40 | Lung Cancer Group CologneOTHER | 1 | Sep 17, 2009 | clinicaltrials |
| NCT00276926 | Study of STI571 in the Treatment of Patients With Idiopathic Hypereosinophilic Syndrome (HES) and Eosinophilic Leukemias | unknown | Phase 2 | — | University of BolognaOTHER | 1 | Sep 15, 2009 | clinicaltrials |
| NCT00801580 | My-HyperCVAD in the Treatment of Relapsed Refractory Adult Acute Lymphoid Leukemia | unknown | Phase 2 | 3 | University of BolognaOTHER | 1 | Sep 15, 2009 | clinicaltrials |
| NCT00973713 | Study of RAD001 in Advanced Cholangiocarcinoma: RADiChol(RADiChol) | unknown | Phase 2 | 27 | Austin HealthOTHER_GOV | 1 | Sep 9, 2009 | clinicaltrials |
| NCT00964132 | Oral NRX 194204 Study in Patients With Advanced Non-Small Cell Lung Cancer (NSCLC) | unknown | Phase 2 | 48 | NuRx Pharmaceuticals, Inc.INDUSTRY | 1 | Sep 3, 2009 | clinicaltrials |
| NCT00966810 | Allogeneic Stem Cell Transplantation in CML With Partial T Cell Depletion | unknown | Phase 2 / Phase 3 | 40 | Rambam Health Care CampusOTHER | 1 | Aug 27, 2009 | clinicaltrials |
| NCT00964457 | Treatment of Patients With Advanced Rectum Cancer With Capecitabine and Oxaliplatin Before, Under and After Radiation and With Adding Cetuximab to K-RAS Wild-type Patients | unknown | Phase 2 | 60 | Copenhagen University Hospital at HerlevOTHER | 1 | Aug 25, 2009 | clinicaltrials |
| NCT00960518 | TACE and Adefovir Compared With Transarterial Chemoembolization (TACE) Alone for Hepatitis B Virus (HBV)-Related Unresectable Hepatocellular Carcinoma (HCC)(TACE) | unknown | Phase 2 | 216 | Tongji UniversityOTHER | 1 | Aug 17, 2009 | clinicaltrials |
| NCT00510939 | Study to Assess the Safety, Tolerability, and Efficacy of Tipifarnib Plus Bortezomib in the Treatment of Acute Myeloid Leukemia(HEMOS AML 0106) | unknown | Phase 2 | 72 | University of BolognaOTHER | 1 | Aug 14, 2009 | clinicaltrials |
| NCT00598624 | Clinical Trial to Evaluate the Safety and Efficacy of Treosulfan Based Conditioning Prior to Allogeneic Haematopoietic Stem Cell Transplantation (HSCT)(AlloTreo) | unknown | Phase 2 | 175 | IRCCS San RaffaeleOTHER | 1 | Aug 11, 2009 | clinicaltrials |
| NCT00794859 | Sorafenib in Previously Treated Malignant Mesothelioma(SMS) | unknown | Phase 2 | 54 | King's College LondonOTHER | 1 | Aug 4, 2009 | clinicaltrials |
| NCT00786331 | Pemetrexed +/- Carboplatin as Second Line Treatment in NSCLC | unknown | Phase 2 | 230 | Gruppo Oncologico Italiano di Ricerca ClinicaOTHER | 1 | Aug 3, 2009 | clinicaltrials |
| NCT00946374 | Prospective Trial on Immunochemotherapy Plus Autologous Stem Cell Transplantation (SCT) and Allogenic SCT in Primary Mantle-Cell-Lymphoma(HD-MCL2003) | unknown | Phase 2 | 20 | Heidelberg UniversityOTHER | 1 | Jul 27, 2009 | clinicaltrials |
| NCT00683761 | A Study of 131I-TM601 in Adults With Recurrent Malignant Glioma | unknown | Phase 1 / Phase 2 | 64 | TransMolecularINDUSTRY | 1 | Jul 17, 2009 | clinicaltrials |
| NCT00938418 | Hypofractionated Intensity Modulated Chemoradiotherapy to Treat Locally Advanced Non-Small Cell Lung Cancer | unknown | Phase 2 | 43 | National University Hospital, SingaporeOTHER | 1 | Jul 13, 2009 | clinicaltrials |
| NCT00069966 | Pixantrone, Cytarabine, Methylprednisolone, and Cisplatin in Treating Patients With Aggressive Non-Hodgkin's Lymphoma in First Relapse | unknown | Phase 2 | — | TheradexINDUSTRY | 2 | Jul 7, 2009 | clinicaltrials |
| NCT00390195 | Randomized Phase I/II of RAD001 in Advanced Hepatocellular Carcinoma (HCC) | unknown | Phase 1 / Phase 2 | 134 | National Health Research Institutes, TaiwanOTHER | 1 | Jul 2, 2009 | clinicaltrials |
| NCT00811200 | Treatment Of Radiation Retinopathy Trial(TORR) | unknown | Phase 2 / Phase 3 | 220 | Leiden University Medical CenterOTHER | 0 | Jul 2, 2009 | clinicaltrials |
| NCT00927797 | Interventional Study on Pentostatin, Cyclophosphamide and Rituximab in Indolent B-Cell Non-Hodgkin-Lymphoma (B-NHL)(PERLL) | unknown | Phase 2 | 185 | Heidelberg UniversityOTHER | 0 | Jun 25, 2009 | clinicaltrials |
| NCT00923637 | Pemetrexed Plus Oxaliplatin as Adjuvant Chemotherapy for Radically Resected Non-Small Cell Lung Cancer | unknown | Phase 2 | 75 | The First Affiliated Hospital of Guangzhou Medical UniversityOTHER | 1 | Jun 18, 2009 | clinicaltrials |
| NCT00466843 | Effects of Antithymocyte Globulin in Adults With Myelodysplastic Syndrome | unknown | Phase 2 | 54 | Office of Rare Diseases (ORD)NIH | 1 | Jun 2, 2009 | clinicaltrials |
| NCT00908336 | Erlotinib and Docetaxel in Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC) After Failure of One Chemotherapy Regimen | unknown | Phase 2 | 70 | Hospital Arnau de VilanovaOTHER | 1 | May 25, 2009 | clinicaltrials |
| NCT00905983 | Biweekly Gemcitabine and Docetaxel as First Line Treatment for Advanced Disease in Elderly Non-Small Cell Lung Cancer (NSCLC) Patients | unknown | Phase 2 | 48 | Hospital Arnau de VilanovaOTHER | 1 | May 21, 2009 | clinicaltrials |
| NCT00906061 | Biweekly Gemcitabine and Docetaxel as First Line Therapy for Advanced Non-Small Cell Lung Cancer (NSCLC) Patients | unknown | Phase 2 | 76 | Hospital Arnau de VilanovaOTHER | 1 | May 21, 2009 | clinicaltrials |
| NCT00894569 | Paclitaxel/Carboplatin With or Without Cetuximab in CUP(PACET-CUP) | unknown | Phase 2 | 150 | Heidelberg UniversityOTHER | 1 | May 14, 2009 | clinicaltrials |
| NCT00003681 | Amifostine With or Without Epoetin Alfa in Treating Patients With Myelodysplastic Syndrome | unknown | Phase 2 | 50 | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 7 | May 12, 2009 | clinicaltrials |
| NCT00890110 | Autologous Vaccination of Stage 4 Renal Cell Carcinoma Combined With Sunitinib(rcc) | unknown | Phase 1 / Phase 2 | 13 | Hadassah Medical OrganizationOTHER | 0 | Apr 29, 2009 | clinicaltrials |
| NCT00886028 | Palliative Treatment With Liposomal Doxorubicin Plus Cisplatin for Patients With Malignant Pleural Mesothelioma | unknown | Phase 2 | 31 | National Institute of CancerologíaOTHER_GOV | 1 | Apr 22, 2009 | clinicaltrials |
| NCT00114309 | 131-I-TM-601 Study in Adults With Recurrent High-Grade Glioma | unknown | Phase 2 | 66 | TransMolecularINDUSTRY | 1 | Apr 3, 2009 | clinicaltrials |
| NCT00722969 | Erlotinib and Sorafenib in Chemonaive Patients With Locally Advanced or Metastatic Non Small Cell Lung Cancer | unknown | Phase 2 | 48 | Universitair Ziekenhuis BrusselOTHER | 1 | Mar 3, 2009 | clinicaltrials |
| NCT00786110 | Sorafenib Plus Paclitaxel in Adreno-Cortical-Cancer Patients(PAXO) | unknown | Phase 2 | 30 | University of Turin, ItalyOTHER | 1 | Feb 24, 2009 | clinicaltrials |
| NCT00816075 | Efficacy of Distilled Water Versus Mitomycin C on Preventing Recurrences of Bladder Cancer After Transurethral Resection | unknown | Phase 2 / Phase 3 | 40 | Bozyaka Training and Research HospitalOTHER | 1 | Feb 17, 2009 | clinicaltrials |
| NCT00844688 | Study of Sorafenib and Gemcitabine in Advanced Hepatocellular Carcinoma (HCC)(HCC) | unknown | Phase 2 | 30 | Combined Military Hospital, PakistanOTHER | 1 | Feb 16, 2009 | clinicaltrials |
| NCT00454519 | Surgery Plus Intraoperative Peritoneal Hyperthermic Chemotherapy (IPHC) to Treat Peritoneal Carcinomatosis(IPHC) | unknown | Phase 2 | 60 | Wuhan UniversityOTHER | 1 | Feb 13, 2009 | clinicaltrials |
| NCT00003097 | Low Fat Diet to Prevent Disease Progression in Patients With Skin Cancer | unknown | Phase 2 | 175 | Baylor College of MedicineOTHER | 1 | Feb 9, 2009 | clinicaltrials |
| NCT00003758 | Combination Chemotherapy in Treating Patients With Relapsed Acute Myelogenous Leukemia | unknown | Phase 2 | 60 | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 7 | Feb 9, 2009 | clinicaltrials |
| NCT00085397 | Vaccine Therapy in Treating Patients With Stage III or Stage IV Melanoma | unknown | Phase 2 | 40 | Dana-Farber Cancer InstituteOTHER | 1 | Feb 9, 2009 | clinicaltrials |
| NCT00270582 | A Study of Weekly Docetaxel Plus Cisplatin Followed by Gemcitabine vs. Gemcitabine Plus Cisplatin Followed by Weekly Docetaxel in the Treatment of Advanced Non-Small-Cell Lung Cancer | unknown | Phase 2 | 58 | Far Eastern Memorial HospitalOTHER | 1 | Feb 9, 2009 | clinicaltrials |
| NCT00384800 | A Phase II Study of Tegafur/Uracil (UFUR®)Plus Thalidomide for the Treatment of Advanced or Metastatic Hepatocellular Carcinoma (HCC) | unknown | Phase 2 | 41 | Far Eastern Memorial HospitalOTHER | 1 | Feb 9, 2009 | clinicaltrials |
Data updated 23 days agoSource updated Jan 5, 2010source: clinicaltrials